Terbium-149 production: a focus on yield and quality improvement towards preclinical application
Terbium-149 production: a focus on yield and quality improvement towards preclinical application
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Terbium-149 (T
1/2
= 4.1 h, E
α
= 3.98 MeV (16.7%), 28 µm range in tissue) is a radionuclide with potential for targeted alpha therapy. Due to the negligible emission of α-emitting daughter nuclides, toxicity to healthy tissue may be reduced in comparison with other α-particle emitters. In this study, terbium-149 was produced via 1.4...
Alternative Titles
Full title
Terbium-149 production: a focus on yield and quality improvement towards preclinical application
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f90309a351d0488db47f6019295a5642
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f90309a351d0488db47f6019295a5642
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-024-53610-2
